FibroGen, Inc. (FGEN)
8.84
+0.34
(+3.94%)
USD |
NASDAQ |
Dec 10, 16:00
8.84
0.00 (0.00%)
After-Hours: 17:43
FibroGen Cash from Investing (Quarterly): 87.16M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| Perspective Therapeutics, Inc. | 13.99M |
| Skye Bioscience, Inc. | 7.967M |
| Theravance Biopharma, Inc. | -100.25M |
| Myomo, Inc. | 0.1897M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.847M |
| Cash from Financing (Quarterly) | -85.92M |
| Free Cash Flow | -17.14M |
| Free Cash Flow Per Share (Quarterly) | -0.459 |
| Free Cash Flow to Equity (Quarterly) | 70.24M |
| Free Cash Flow to Firm (Quarterly) | 0.227M |
| Free Cash Flow Yield | -6.86% |